Luigi Sacco University Hospital Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Milan Italy (1927)

Organization Overview

First Clinical Trial
2006
NCT01026857
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Elisa Colella, M.D. | luigi sacco hospital milano | Luigi Sacco Hospital - Phase I Department - Via G. B. Grassi 74 20157 Milano | Massimo Arquati | Massimo Galli, M.D. | Ospedale L. Sacco | Ospedale L. Sacco di Milano, Oncologia | Ospedale L. Sacco - Milan - Italy | Ospedale L. Sacco - Polo Universitario | Ospedale L. Sacco – Polo Universitario | Spinello Antinori | Umberto Russo | Valentina Di Cristo, M.D.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 3)

Colitis (Phase 2)

Colitis, Ulcerative (Phase 2)

Dermatitis (Phase 3)

Dermatitis, Atopic (Phase 3)

Eczema (Phase 3)

HIV Infections (Phase 4)

Infections (Phase 4)

Muscular Dystrophies (Phase 1)

Muscular Dystrophy, Duchenne (Phase 1)

Rhinitis, Allergic, Seasonal (Phase 3)

Stomach Neoplasms (Phase 3)

Ulcer (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 18